Donor notification of permanent deferral: a qualitative study on the perceptions and practices of notifier and blood donor in Mexico

Author:

Serrano-Delgado V Moisés,Valdez-Martínez EdithORCID,Márquez-González Horacio

Abstract

Abstract Background Informing about permanent deferral requires a process that links the notifier with the donor in a particular way. Little is known about the type of information and how it is disclosed to the donors. The current study aimed to examine perceptions and practices of notifier and blood donor within the framework of the notification process of permanent deferral and from the perspective of the notifier―blood donor relationship. Methods A qualitative study with in-depth interviews. The participants were 13 notifiers and 25 permanently deferred donors. Participants were recruited from a national blood bank and a state’s blood bank. The entire dataset/narratives were analysed using the method of thematic analysis. Results The disclosure of permanent deferral was understood as a matter of disclosing the serological test results and their medical meaning along with a concise explanation of the deferral status with regard to future blood donation and the plan to be followed. The notifiers preferred to act in accordance with the standard protocol despite acknowledging the adverse psychological and social effects to which donors are exposed when they are informed of the possible disease and the consequent permanent deferral. Donors described a variety of psychological and social affectations. They valued honesty in the communication, the clarity of the information provided and a greater involvement of the notifier. Conclusion Even though the notification process does not imply that medical care is being offered to donors, the notifier is the administrator of the well-being of the donor. Notification must not be considered as something apart from care, since it is intimately related to the health of each of the donors and their medical care.

Publisher

Springer Science and Business Media LLC

Subject

Health Policy

Reference22 articles.

1. Food and Drug Administration. DHHS 21 CFR Parts 606 and 630 [Docket No. 98N-0607] General Requirements for Blood. Blood Components, and Blood Derivates; Donor Notification. 2001. https://www.govinfo.gov/content/pkg/FR-2001-06-11/pdf/01-14409.pdf. Accessed 28 Jan 2021.

2. Council of Europe Resolutions, Recommendations and Convention. Blood and Blood Components. France: European Directorate for the Quality of Medicines and HealthCare. 2012. www.edqm.eu Accessed 28 Jan 2021.

3. Estados Unidos Mexicanos. Secretaría de Salud. Norma Oficial Mexicana NOM 253-SSA1-2012, Para la Disposición de Sangre Humana y Sus Componentes Con Fines Terapéuticos. Diario Oficial. 2012. http://www.cnts.salud.gob.mx/descargas/NOM-253-SSA1-2012.pdf. Accessed 28 Jan 2021.

4. Estados Unidos Mexicanos. Secretaría de Salud. Centro Nacional de la Transfusión Sanguínea. 2021. http://cnts.salud.gob.mx Accessed 28 Jan 2021.

5. Estados Unidos Mexicanos. Secretaría de Salud. Comisión Federal para la Protección contra Riesgos Sanitarios. 2021. https://www.gob.mx/cofepris Accessed 28 Jan 2021.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3